Inhibitory Effects of Ecklonia cava Extract on High Glucose-Induced Hepatic Stellate Cell Activation

Nonalcoholic steatohepatitis (NASH) is a disease closely associated with obesity and diabetes. A prevalence of type 2 diabetes and a high body mass index in cryptogenic cirrhosis may imply that obesity leads to cirrhosis. Here, we examined the effects of an extract of Ecklonia cava, a brown algae, o...

Full description

Bibliographic Details
Main Authors: Akiko Kojima-Yuasa, Akiko Tamura, Masaki Terada, Isao Matsui-Yuasa, Kumiko Yokogawa
Format: Article
Language:English
Published: MDPI AG 2011-12-01
Series:Marine Drugs
Subjects:
Online Access:http://www.mdpi.com/1660-3397/9/12/2793/
_version_ 1828114792256110592
author Akiko Kojima-Yuasa
Akiko Tamura
Masaki Terada
Isao Matsui-Yuasa
Kumiko Yokogawa
author_facet Akiko Kojima-Yuasa
Akiko Tamura
Masaki Terada
Isao Matsui-Yuasa
Kumiko Yokogawa
author_sort Akiko Kojima-Yuasa
collection DOAJ
description Nonalcoholic steatohepatitis (NASH) is a disease closely associated with obesity and diabetes. A prevalence of type 2 diabetes and a high body mass index in cryptogenic cirrhosis may imply that obesity leads to cirrhosis. Here, we examined the effects of an extract of Ecklonia cava, a brown algae, on the activation of high glucose-induced hepatic stellate cells (HSCs), key players in hepatic fibrosis. Isolated HSCs were incubated with or without a high glucose concentration. Ecklonia cava extract (ECE) was added to the culture simultaneously with the high glucose. Treatment with high glucose stimulated expression of type I collagen and α-smooth muscle actin, which are markers of activation in HSCs, in a dose-dependent manner. The activation of high glucose-treated HSCs was suppressed by the ECE. An increase in the formation of intracellular reactive oxygen species (ROS) and a decrease in intracellular glutathione levels were observed soon after treatment with high glucose, and these changes were suppressed by the simultaneous addition of ECE. High glucose levels stimulated the secretion of bioactive transforming growth factor-β (TGF-β) from the cells, and the stimulation was also suppressed by treating the HSCs with ECE. These results suggest that the suppression of high glucose-induced HSC activation by ECE is mediated through the inhibition of ROS and/or GSH and the downregulation of TGF-β secretion. ECE is useful for preventing the development of diabetic liver fibrosis.
first_indexed 2024-04-11T12:31:40Z
format Article
id doaj.art-cc7506f14a2c4891affb58482258cc83
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-04-11T12:31:40Z
publishDate 2011-12-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-cc7506f14a2c4891affb58482258cc832022-12-22T04:23:45ZengMDPI AGMarine Drugs1660-33972011-12-019122793280810.3390/md9122793Inhibitory Effects of Ecklonia cava Extract on High Glucose-Induced Hepatic Stellate Cell ActivationAkiko Kojima-YuasaAkiko TamuraMasaki TeradaIsao Matsui-YuasaKumiko YokogawaNonalcoholic steatohepatitis (NASH) is a disease closely associated with obesity and diabetes. A prevalence of type 2 diabetes and a high body mass index in cryptogenic cirrhosis may imply that obesity leads to cirrhosis. Here, we examined the effects of an extract of Ecklonia cava, a brown algae, on the activation of high glucose-induced hepatic stellate cells (HSCs), key players in hepatic fibrosis. Isolated HSCs were incubated with or without a high glucose concentration. Ecklonia cava extract (ECE) was added to the culture simultaneously with the high glucose. Treatment with high glucose stimulated expression of type I collagen and α-smooth muscle actin, which are markers of activation in HSCs, in a dose-dependent manner. The activation of high glucose-treated HSCs was suppressed by the ECE. An increase in the formation of intracellular reactive oxygen species (ROS) and a decrease in intracellular glutathione levels were observed soon after treatment with high glucose, and these changes were suppressed by the simultaneous addition of ECE. High glucose levels stimulated the secretion of bioactive transforming growth factor-β (TGF-β) from the cells, and the stimulation was also suppressed by treating the HSCs with ECE. These results suggest that the suppression of high glucose-induced HSC activation by ECE is mediated through the inhibition of ROS and/or GSH and the downregulation of TGF-β secretion. ECE is useful for preventing the development of diabetic liver fibrosis.http://www.mdpi.com/1660-3397/9/12/2793/type I collagenEcklonia cavareactive oxygen speciestransforming growth factor-βhigh glucosehepatic stellate cells
spellingShingle Akiko Kojima-Yuasa
Akiko Tamura
Masaki Terada
Isao Matsui-Yuasa
Kumiko Yokogawa
Inhibitory Effects of Ecklonia cava Extract on High Glucose-Induced Hepatic Stellate Cell Activation
Marine Drugs
type I collagen
Ecklonia cava
reactive oxygen species
transforming growth factor-β
high glucose
hepatic stellate cells
title Inhibitory Effects of Ecklonia cava Extract on High Glucose-Induced Hepatic Stellate Cell Activation
title_full Inhibitory Effects of Ecklonia cava Extract on High Glucose-Induced Hepatic Stellate Cell Activation
title_fullStr Inhibitory Effects of Ecklonia cava Extract on High Glucose-Induced Hepatic Stellate Cell Activation
title_full_unstemmed Inhibitory Effects of Ecklonia cava Extract on High Glucose-Induced Hepatic Stellate Cell Activation
title_short Inhibitory Effects of Ecklonia cava Extract on High Glucose-Induced Hepatic Stellate Cell Activation
title_sort inhibitory effects of ecklonia cava extract on high glucose induced hepatic stellate cell activation
topic type I collagen
Ecklonia cava
reactive oxygen species
transforming growth factor-β
high glucose
hepatic stellate cells
url http://www.mdpi.com/1660-3397/9/12/2793/
work_keys_str_mv AT akikokojimayuasa inhibitoryeffectsofeckloniacavaextractonhighglucoseinducedhepaticstellatecellactivation
AT akikotamura inhibitoryeffectsofeckloniacavaextractonhighglucoseinducedhepaticstellatecellactivation
AT masakiterada inhibitoryeffectsofeckloniacavaextractonhighglucoseinducedhepaticstellatecellactivation
AT isaomatsuiyuasa inhibitoryeffectsofeckloniacavaextractonhighglucoseinducedhepaticstellatecellactivation
AT kumikoyokogawa inhibitoryeffectsofeckloniacavaextractonhighglucoseinducedhepaticstellatecellactivation